The AMMnet Advisory Board is made up of experts in malaria, health analytics, and capacity development. They provide strategic guidance to AMMnet’s Board and offer independent evaluation of its performance to help ensure the network’s continued growth and impact.
2025-Present
Dr Victor Alegana is an Epidemiologist at the WHO Regional Office for Africa with Tropical and Vector-Borne Diseases (TVD). His expertise includes spatial and spatio-temporal disease modelling and burden estimation, particularly in the areas of tropical and vector-borne diseases, vaccine-preventable diseases, HIV, and neglected tropical diseases. Previously, he served as a Research Fellow at the KEMRI-Wellcome Trust Research Programme. He has a strong interest in using data for decision-making and policy development, which encompasses the use of routine health data and the application of spatial statistical data science to address public health issues in Africa. His work includes broad areas of population health, particularly spatial epidemiology (disease burden estimation), healthcare access, the delivery of health interventions, and monitoring Sustainable Development Goals related to vulnerable populations.
2025-Present
Dr Victor Alegana is an Epidemiologist at the WHO Regional Office for Africa with Tropical and Vector-Borne Diseases (TVD). His expertise includes spatial and spatio-temporal disease modelling and burden estimation, particularly in the areas of tropical and vector-borne diseases, vaccine-preventable diseases, HIV, and neglected tropical diseases. Previously, he served as a Research Fellow at the KEMRI-Wellcome Trust Research Programme. He has a strong interest in using data for decision-making and policy development, which encompasses the use of routine health data and the application of spatial statistical data science to address public health issues in Africa. His work includes broad areas of population health, particularly spatial epidemiology (disease burden estimation), healthcare access, the delivery of health interventions, and monitoring Sustainable Development Goals related to vulnerable populations.
2025-Present
Alioune Camara, Professor of Epidemiology, has been coordinator of Guinea’s National Malaria Control Program (NMCP) since 2022. He has a Doctorate in Medicine from Gamal Abdel Nasser University (UGAN) in Conakry and a PhD from University of Rennes 1 in France. At the Faculty of Health Sciences and Techniques of UGAN, he is a teacher-researcher, directs the Master of Public Health program, leads instruction in epidemiology, and is a committee member for the PhD program in public health and the Master’s programs in microbiology and immunology. He is involved in multiple research projects spanning malaria, tuberculosis, HIV and One Health. Within the NMCP, Prof Camara previously held the positions of monitoring and evaluation support officer, research manager and deputy national coordinator. In his role as national coordinator, he innovates by focusing on the quality of interventions for the benefit of the population.
2025-Present
Alioune Camara, Professor of Epidemiology, has been coordinator of Guinea’s National Malaria Control Program (NMCP) since 2022. He has a Doctorate in Medicine from Gamal Abdel Nasser University (UGAN) in Conakry and a PhD from University of Rennes 1 in France. At the Faculty of Health Sciences and Techniques of UGAN, he is a teacher-researcher, directs the Master of Public Health program, leads instruction in epidemiology, and is a committee member for the PhD program in public health and the Master’s programs in microbiology and immunology. He is involved in multiple research projects spanning malaria, tuberculosis, HIV and One Health. Within the NMCP, Prof Camara previously held the positions of monitoring and evaluation support officer, research manager and deputy national coordinator. In his role as national coordinator, he innovates by focusing on the quality of interventions for the benefit of the population.
2024-Present
Professor Deirdre Hollingsworth is an infectious disease epidemiologist who uses mathematical models and statistical analyses to study the evolution and transmission dynamics of infectious diseases with the aim of informing the design of more effective control interventions. She joined the Oxford Big Data Institute in 2017, where she leads the Bill and Melinda Gates Foundation-funded neglected tropical diseases modelling consortium.
2024-Present
Professor Deirdre Hollingsworth is an infectious disease epidemiologist who uses mathematical models and statistical analyses to study the evolution and transmission dynamics of infectious diseases with the aim of informing the design of more effective control interventions. She joined the Oxford Big Data Institute in 2017, where she leads the Bill and Melinda Gates Foundation-funded neglected tropical diseases modelling consortium.
.jpg)
2025-Present
Dr Corine Ngufor is a Reader in Vector Biology at the Liverpool School of Tropical Medicine with extensive experience leading malaria and vector-control research. Her work focuses on the development and evaluation of new prevention tools, with a strong interest in the use of modelling to inform product development and policy. Based in Benin, she leads large multidisciplinary teams and collaborates with governments, WHO, and international partners. She has delivered major global health projects spanning next-generation vector control, chemoprevention, diagnostics, and malaria vaccines. Dr Ngufor is also Co-Chair of the RBM Vector Control Working Group and a member of the WHO Malaria Policy Advisory Group, where she supports the development of best practices and policy.
2025-Present
Dr Corine Ngufor is a Reader in Vector Biology at the Liverpool School of Tropical Medicine with extensive experience leading malaria and vector-control research. Her work focuses on the development and evaluation of new prevention tools, with a strong interest in the use of modelling to inform product development and policy. Based in Benin, she leads large multidisciplinary teams and collaborates with governments, WHO, and international partners. She has delivered major global health projects spanning next-generation vector control, chemoprevention, diagnostics, and malaria vaccines. Dr Ngufor is also Co-Chair of the RBM Vector Control Working Group and a member of the WHO Malaria Policy Advisory Group, where she supports the development of best practices and policy.
2022-Present
Sheetal SILAL is the Director the Modelling and Simulation Hub, Africa (MASHA) and associate Professor in the Department of Statistical Sciences at the University of Cape Town (UCT). She is an Honorary Visiting Research Fellow in Tropical Disease Modelling at the Nuffield Department of Medicine at Oxford University.
2022-Present
Sheetal SILAL is the Director the Modelling and Simulation Hub, Africa (MASHA) and associate Professor in the Department of Statistical Sciences at the University of Cape Town (UCT). She is an Honorary Visiting Research Fellow in Tropical Disease Modelling at the Nuffield Department of Medicine at Oxford University.
2025-Present
Dr. Andre‑Marie Tchouatieu is Head of Global Medical Affairs & Evidence at Medicines for Malaria Venture (MMV) since January 2026. He leads real‑world evidence generation, medical education, and strategic partnerships to accelerate the safe, equitable adoption of MMV‑supported interventions across malaria‑endemic regions. Previously Director of Access & Product Management, he designed and led MMV’s Access chemoprevention strategy, guiding cross‑functional teams and multi‑country coalitions from concept to delivery. Earlier, Dr. Tchouatieu held senior medical leadership roles at Sanofi—Country Manager (Burundi), Medical Advisor for Eastern Africa (Nairobi), and Global Malaria Senior Medical Manager (Paris)—and served as a field physician with Médecins Sans Frontières -France in East Africa. A founder member and current Secretary of the Seasonal Malaria Chemoprevention (SMC) Alliance within the Roll Back Malaria network, he focuses on pragmatic, scalable solutions that strengthen campaign delivery and access. He is a strong believer in a bright health system for LMICs. He trained at the University of Burundi and completed advanced studies in health systems (Swiss TPH/University of Basel) and the Science of Eradication: Malaria course (IsGlobal/Harvard/Swiss TPH).
2025-Present
Dr. Andre‑Marie Tchouatieu is Head of Global Medical Affairs & Evidence at Medicines for Malaria Venture (MMV) since January 2026. He leads real‑world evidence generation, medical education, and strategic partnerships to accelerate the safe, equitable adoption of MMV‑supported interventions across malaria‑endemic regions. Previously Director of Access & Product Management, he designed and led MMV’s Access chemoprevention strategy, guiding cross‑functional teams and multi‑country coalitions from concept to delivery. Earlier, Dr. Tchouatieu held senior medical leadership roles at Sanofi—Country Manager (Burundi), Medical Advisor for Eastern Africa (Nairobi), and Global Malaria Senior Medical Manager (Paris)—and served as a field physician with Médecins Sans Frontières -France in East Africa. A founder member and current Secretary of the Seasonal Malaria Chemoprevention (SMC) Alliance within the Roll Back Malaria network, he focuses on pragmatic, scalable solutions that strengthen campaign delivery and access. He is a strong believer in a bright health system for LMICs. He trained at the University of Burundi and completed advanced studies in health systems (Swiss TPH/University of Basel) and the Science of Eradication: Malaria course (IsGlobal/Harvard/Swiss TPH).
Former Advisory Board Members
2024-2025
2024-2025
2024-2025
2024-2025
2022-2025
2022-2025
